Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials

By sjmartinez • July 25, 2022

Hamid A, Anker MS, Ruckdeschel JC, Khan MS, Tharwani A, Oshunbade AA, Kipchumba RK, Thigpen SC, Anker SD, Fonarow GC, Hall ME, Butler J. Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials. J Am Heart Assoc. 2022 Jul 25:e025206. doi: 10.1161/JAHA.121.025206. Epub ahead of print. PMID: 35876414.

Tags: cancer therapy, cardio‐oncology, Cardiology/Epi, cardiovascular disease, pharmacotherapy, Publications, safety

CT Emphysema Subtypes and Cardiac Hemodynamics Estimated on Magnetic Resonance Imaging: The MESA COPD Study

Hermann EA, Yang JX, Angelini E, Balte P, Bluemke DA, Carr J, Derlin K, Gomes AS, Habibi M, Hoffman EA, Johns C, Kawut SM, Kiely[...]

Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis

Packard RRS, deKemp RA, Knuuti J, Moody JB, Renaud JM, Saraste A, Slomka PJ. Quantitative approaches to 18F-flurpiridaz positron emission tomography image analysis. J Nucl Cardiol.[...]

Alcohol Exposure Among Patients With Dilated Cardiomyopathy and Their First-Degree Relatives: The DCM Precision Medicine Study

Jimenez J, Ni H, Katz SD, Haas GJ, Cao J, Rubens M, Chaparro S, Saxena A, Hofmeyer M, Kransdorf E, Ewald GA, Morris AA, Owens[...]